Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans

Diabetes

Volumn 46, Issue 7, 1997, Pages 1111-1119

  Lewis, Gary F ^a,b   Vranic, Mladen ^a   Harley, Patricia ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCAGON; GLUCOSE; HEPARIN; INSULIN; INTRALIPID; TOLBUTAMIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE UTILIZATION; HUMAN; HUMAN EXPERIMENT; INSULIN INFUSION; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; LIVER METABOLISM; MALE; NORMAL HUMAN; PORTAL VEIN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0030975131     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.7.1111     Document Type: Article

References (44)

1. Ader M, Bergman RN: Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258:E1020-E1032, 1990
2. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL, Vranic M: Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90:1769-1777, 1992
3. Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD: A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 45:1594-1604, 1996
4. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
5. Rebrin K, Steil GM, Mittelman SD, Bergman RM: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
6. Prager R, Wallace P, Olefsky JM: Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36:607-611, 1987
7. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A: Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45:454-462, 1996
8. Boden G, Chen X, Desantis RA, Kendrick Z: Effects of insulin on fatty acid reesterification in healthy subjects. Diabetes 42:1588-1593, 1993
9. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA: Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 259:E736-E750, 1990
10. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
11. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213, 1989
12. Boden G, Jadali F: Effects of lipid on basal carbohydrate metabolism in nor- mal men. Diabetes 40:686-692, 1991
13. Clore JN, Glickman PS, Helm ST, Nestler JE, Blackard WG: Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men. Diabetes 40:1033-1040, 1991
14. Shi ZQ, Giacca A, Yamatani K, Fisher SJ, Lickley HL, Vranic M: Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatized dogs. Am J Physiol 264:E334-E341, 1993
15. Yamatani K, Shi ZQ, Giacca A, Gupta R, Fisher S, Lickley HL, Vranic M: Role of FFA-glucose cycle in glucoregulation during exercise in total absence of insulin. Am J Physiol 263:E646-E653, 1992
16. Saloranta C, Taskinen MR, Widen E, Harkonen M, Melander A, Groop L: Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 42:1559-1566, 1993
17. Fanelli C, Calderone S, Epifano L, De Vincenzo A, Modarelli F, Panipanelli S, Perriello G, De Feo P, Brunetti P, Gerich JE, Bolli GB: Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92:1617-1622, 1993
18. Sindelar DK, Chu C, Rohlie M, Neal DW, Swift LL, Cherrington AD: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46:187-196, 1997
19. Lewis GF, Steiner G, Polonsky KS, Weller B, Zinman B: A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion. J Clin Endocrinol Metab 79:66-70, 1994
20. Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G: VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am J Physiol 267:E566-E572, 1994
21. 3H]glucose. Am J Physiol 258:E228-E233, 1990
22. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
23. Finegood DT, Bergman RN, Vranic M: Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37:1025-1034, 1988
24. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
25. Finegood DT, Bergman RN: Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol 244:E472-E479, 1983
26. Bradley DC, Steil GM, Bergman RN: Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. Am J Physiol 264:E902-E911, 1993
27. De Feo P, Perriello G, De Cosmo S, Ventura MM, Campbell PJ, Brunetti, P, Gerich JE, Bolli GB: Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35:563-569, 1986
28. Campra JL, Reynolds TB: The hepatic circulation. In The Liver: Biology and Pathobiology. Arias IM, Popper H, Schachter D, Shafritz DA, Eds. New York, Raven Press, 1982, p. 627-645
29. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptide antisera. Diabetes 21 (Suppl. 1):170-177, 1978
30. Giacca A, Fisher SJ, McCall RH, Shi ZQ, Vranic M: Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon. Endocrinology 138:999-1007, 1997
31. Lewis GF, Vranic M, Giacca A: Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am J Physiol 272:E371-E378, 1997
32. Groop LC, Bonadonna RC, Shank M, Petrides AS, DeFronzo RA: Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest 87:83-89, 1991
33. Yki-Jarvinen H, Puhakainen I, Saloranta C, Groop L, Taskinen MR: Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260:E680-E689, 1991
34. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA: Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257:E49-E56, 1989
35. Saloranta C, Koivisto V, Widen E, Falholt K, DeFronzo RA, Harkonen M, Groop L: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264:E599-E605, 1993
36. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen MR, Groop L: Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:409-415, 1991
37. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
38. Hers HG, Hue L: Gluconeogenesis and related aspects of glycolysis (Review). Ann Rev Biochem 52:617-653, 1983
39. Jahoor F, Peters EJ, Wolfe RR: The relationship between gluconeogenic substrate supply and glucose production in humans. Am J Physiol 258:E288-E296, 1990
40. Cersosimo E, Judd RL, Miles JM: Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest 93:2584-2589, 1994
41. Boden G, Chen X, Rosner J, Barton M: Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239-1242, 1995
42. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varrichio M, D'Onofrio F: Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295-1299, 1996
43. Sako Y, Grill VE: A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580-1589, 1990
44. Zhou YP, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994